WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations-Reference-Cited by-同舟云学术

WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations

Published:2022-03 Issue:14 Volume:40 Page:2140-2149
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Singh Jerome Amir,Kochhar Sonali,Wolff Jonathan,Atuire Caesar,Bhan Anant,Emanuel Ezekiel,Faden Ruth,Ghimire Prakash,Greco Dirceu,Ho Calvin,Moon Suerie,Shamsi-Gooshki Ehsan,Touré Aissatou,Thomé Beatriz,Smith Maxwell J.,Upshur Ross E.G.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference64 articles.

1. Krause PR, Fleming TR, Longini IM, Peto R, Briand S, Heymann DL, Beral V, Snape MD, Rees H, Ropero AM, Balicer RD, Cramer JP, Muñoz-Fontela C Gruber M, Sa Gaspar R, Singh JA, Subbarao K, Van Kerkhove MD, Swaminathan S, Ryan MJ, Henao‐Restrepo A. SARS-CoV-2 variants and vaccines. New England J Med 2021. DOI: 10.1056/NEJMsr2105280. https://www.nejm.org/doi/full/10.1056/NEJMsr2105280.

2. World Health Organisation. Tracking SARS-CoV-2 variants. Published online February 3, 2022. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.

3. WHO Technical Advisory Group on COVID-19 Vaccine Composition. Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC). Published online January 11, 2022. https://www.who.int/news/item/11-01-2022-interim-statement-on-covid-19-vaccines-in-the-context-of-the-circulation-of-the-omicron-sars-cov-2-variant-from-the-who-technical-advisory-group-on-covid-19-vaccine-composition.

4. Pfizer. Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age. Published online January 25, 2022. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-initiate-study-evaluate-omicron-based.

5. WHO. COVID-19 vaccine tracker and landscape. Published online January 25, 2022. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research ethics preparedness during outbreaks and public health emergencies: Focus on community engagement;Research Ethics;2024-05-17

2. Vaccine safety, efficacy, and ethical considerations;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

3. Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable;Expert Review of Vaccines;2023-12-12

4. If it walks like a duck…: Monitored Emergency Use of Unregistered and Experimental Interventions (MEURI) is research;Journal of Medical Ethics;2023-11-23

5. FcγRIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet activation;Frontiers in Cardiovascular Medicine;2023-11-15